翰宇药业：董事兼执行总裁PINXIANG YU辞任

Core Points - The company announced the retirement of its director and CEO, Ms. Pinxiangyu, effective immediately upon submission of her resignation report to the board [1] - Ms. Pinxiangyu holds 530,400 shares in the company, representing 0.06% of the total share capital [1] - Following her resignation, she will not hold any positions within the company or its subsidiaries [1] Shareholding and Transfer Restrictions - Ms. Pinxiangyu has committed to not transferring more than 25% of her total shareholding during her tenure and for six months after her term ends [1] - She is prohibited from transferring her shares within six months following her departure from the company [1]